ANTIHISTAMINES REDUCE BLOODRETINAL BARRIER PERMEABILITY IN TYPE I (INSULIN-DEPENDENT) DIABETIC PATIENTS WITH NONPROLIFERATIVE RETINOPATHY: A Pilot Study